CDK Inhibitors approved by PBAC 20 April 2018
CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue. See the link below for further information https://www.bcna.org.au/news/2018/04/cdk-i...
Forum Discussion
Wendy55
This is the FDA ( States ) approval from 2015
https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm549978.htm
- and how Pfizer phrased it in relation to the body of evidence - the reality is that if clinically appropriate most women can access it in the States ( they have odd insurance policies that complicate things ...) . There is sometimes a pattern where resistance to hormone therapy develops and using chemo resensitizes one to hormone therapy ( not always but it can happen) so I think in this context one goes with what the clinical oncologist decides is best, not just first line.
PBAC approved what Pfizer asked for and it is listed as initial not first line - iffy I know- so it may be opened to interpretation, firngers crossed.
Definetely check with your oncologist - and also maybe keep an eye out Pfizer may put out a compassionate access program for "others" once the deal with PBS happens.
This is the FDA ( States ) approval from 2015
https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm549978.htm
- and how Pfizer phrased it in relation to the body of evidence - the reality is that if clinically appropriate most women can access it in the States ( they have odd insurance policies that complicate things ...) . There is sometimes a pattern where resistance to hormone therapy develops and using chemo resensitizes one to hormone therapy ( not always but it can happen) so I think in this context one goes with what the clinical oncologist decides is best, not just first line.
PBAC approved what Pfizer asked for and it is listed as initial not first line - iffy I know- so it may be opened to interpretation, firngers crossed.
Definetely check with your oncologist - and also maybe keep an eye out Pfizer may put out a compassionate access program for "others" once the deal with PBS happens.